Vendor, Worcester, MA
Microbiotix, Inc.
UEI SCNKBDM341T1, CAGE 465F8
2 awards and $3,787,586 obligated between June 18, 2026 and August 26, 2026, 100% under full and open competition, against 11.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $3,787,586 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93023C00001Definitive Contract, July 9, 2026, Full and Open Competition, 10 offers | National Institutes of Health NiaidNational Institutes of Health | EO14398 to Develop the PPZ Series of Small Molecule Pan-Filovirus Entry Inhibitors Through Lead Optimization, Selection of a Preclinical CanNAICS 541715, PSC AN12 | $3,787,586 |
| 75N93020C00019Definitive Contract, June 18, 2026, Full and Open Competition, 12 offers | National Institutes of Health NiaidNational Institutes of Health | To Develop Phenoxyacetamide T3SS Inhibitors as Adjunctive Agents to Antibacterial Therapy for MDR P. Aeruginosa Infections.NAICS 541715, PSC AN12 | $0 |
- Places of performance
- Massachusetts
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 4 across 2 awards